Literature DB >> 3656577

Endoscopic treatment of vesicoureteral reflux in children.

C C Schulman1, J Simon, D Pamart, F E Avni.   

Abstract

We treated 35 children with different grades of vesicoureteral reflux with endoscopic injection of polytetrafluoroethylene (Teflon) behind the intravesical ureter. A total of 51 refluxing ureters was treated. In all cases absence of reflux was noted on a cystogram performed immediately after the procedure. At 3 to 12-month followup reflux was absent in 32 ureters and it recurred in 4, including 3 ureters with low grade reflux. A second injection of polytetrafluoroethylene in 3 ureters resulted in its absence, while in 1 case reimplantation was performed. The procedure is simple and reliable. An operation is avoided, hospital stay is reduced and no complications have occurred.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3656577     DOI: 10.1016/s0022-5347(17)43467-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

Review 1.  Management of urinary tract infection and vesicoureteric reflux in children. 2. The case for surgery.

Authors:  B O'Donnell
Journal:  BMJ       Date:  1990-05-26

2.  Subureteric polydimethylsiloxane injection in the treatment of vesico-ureteric reflux.

Authors:  R Ozyavuz; G K Ozgur; A K Yuzuncu
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

3.  Teflon injection in the treatment of vesicoureteral reflux: a promising alternative for surgery.

Authors:  F Simşek; Y Ilker; A Akdaş; L Türkeri
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

Review 4.  Surgical management of vesicoureteral reflux in pediatric patients.

Authors:  Axel Heidenreich; Enver Ozgur; Tanja Becker; Gerald Haupt
Journal:  World J Urol       Date:  2004-06-18       Impact factor: 4.226

Review 5.  Does deflux alter the paradigm for the management of children with vesicoureteral reflux?

Authors:  Ian A Aaronson
Journal:  Curr Urol Rep       Date:  2005-03       Impact factor: 2.862

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.